Certain types of university intellectual property can sometimes prove difficult to commercialise through traditional routes, usually because it is at an early stage of development, or because it presents enough uncertainty for companies to risk an investment.
University Technology’s Easy Access portal offers access to this type of intellectual property at no cost, to enable companies to evaluate it and put it to use quickly, with reduced risk.
Easy Access uses quick and simple licence agreements to fast-track the transfer of knowledge and expertise from Scotland’s universities to industry, so that these technologies may be developed for the benefit of the economy and society.
Through this initiative, our aim is to make it easier for Scottish universities and industry to work together and build strong, long-term relationships with industry partners.
Showing 41 - 48 of 48 opportunities
The University of Glasgow has developed a (Ad-hTR-NTR) which has been extensively tested on Ovarian cancer cells.
The University of Glasgow have identified a novel way of looking at proteins that bind glycolipids in membranes in a new process called combinatorial glycorray.
Researchers at the University of Glasgow and the Ifakara Health Institute have developed a new mosquito electrocuting trap (MET) that can be used as a research tool to safely and accurately estimate mosquito biting rates on people and cattle.
Researchers at the University of Glasgow have developed a Wireless Electroencephalogram Neuro-feedback System for rehabilitation and the treatment of chronic pain.
Researchers at the University of Glasgow have developed a computational method for fully characterising the T cell receptors (TCRs) in antigen-responsive cell populations.
Researchers at the University of Glasgow have developed tactile skin to be applied to robotics, prosthetics, healthcare and surgical instrumentation.
An effective method for delivery of small molecules to the colon has been developed by researchers at the University of Glasgow and Imperial College London which targets receptors in the region of the gut thought to be involved in appetite regulation and metabolic control.
Researchers at the University of Glasgow have created a new technology that allows safe and efficient delivery of growth factors, in particular recombinant human bone morphogenetic protein-2 (rhBMP-2) for bone tissue engineering.
Please select the market sector you are interested in.
Please select the university you are interested in.
Show only Easy Access opportunities.
Narrow your search with a few keywords.
Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities